Arena Therapeutics, Inc.

From the company

Arena Therapeutics is a start-up dedicated to developing Targeted Brain Modulation (Deep Brain Stimulation) as a treatment for patients diagnosed with Parkinson's disease. Its investigational therapy is designed to stimulate specific brain tracts that may slow disease progression in early-stage Parkinson's disease, and is based on research and Class II clinical evidence performed at Vanderbilt University. The company holds an exclusive license to pre-clinical, clinical, and intellectual property from Vanderbilt University and is preparing to launch a piv